OBJECTIVE: To assess the feasibility and effectiveness of an ED-based tuberculosis (TB) screening program. METHODS: A TB screening program of adult ED patients was conducted at a university hospital ED with 46,000 annual visits that serves a poor urban community. Patients were screened on weekdays during business hours. ED patients were counseled about the disease and the screening procedure and, after consent, purified protein derivative (PPD) tests were placed. Patients returned in 48-72 hours for reaction reading and post-test counseling. PPD-positive patients received a physical examination, chest x-ray, and HIV testing and were referred to a city TB clinic for possible treatment. RESULTS: Overall, 873 patients were counseled, 630 were eligible for screening, and 374 (59.4%) consented to PPD testing. Of the 203 (54.1%) who returned, 32 (15.8%) were PPD-positive. No active case was detected, but 26 patients were referred to the health department. Eighteen kept their appointments and all 13 who were started on therapy completed treatment. Targeted screening of groups aged 55 years or more, nonwhite groups, and those with other high-risk factors would detect 84% of PPD-positive cases while testing only 48% of eligible patients. CONCLUSION: An ED-based TB screening program is feasible and can identify many patients requiring treatment. Targeted screening of high-risk groups could reduce the program cost, but would miss some cases.
OBJECTIVE: To assess the feasibility and effectiveness of an ED-based tuberculosis (TB) screening program. METHODS: A TB screening program of adult ED patients was conducted at a university hospital ED with 46,000 annual visits that serves a poor urban community. Patients were screened on weekdays during business hours. ED patients were counseled about the disease and the screening procedure and, after consent, purified protein derivative (PPD) tests were placed. Patients returned in 48-72 hours for reaction reading and post-test counseling. PPD-positive patients received a physical examination, chest x-ray, and HIV testing and were referred to a city TB clinic for possible treatment. RESULTS: Overall, 873 patients were counseled, 630 were eligible for screening, and 374 (59.4%) consented to PPD testing. Of the 203 (54.1%) who returned, 32 (15.8%) were PPD-positive. No active case was detected, but 26 patients were referred to the health department. Eighteen kept their appointments and all 13 who were started on therapy completed treatment. Targeted screening of groups aged 55 years or more, nonwhite groups, and those with other high-risk factors would detect 84% of PPD-positive cases while testing only 48% of eligible patients. CONCLUSION: An ED-based TB screening program is feasible and can identify many patients requiring treatment. Targeted screening of high-risk groups could reduce the program cost, but would miss some cases.
Authors: C James Holliman; Terrence M Mulligan; Robert E Suter; Peter Cameron; Lee Wallis; Philip D Anderson; Kathleen Clem Journal: Int J Emerg Med Date: 2011-07-22
Authors: Líbia C R V Moura; Ricardo A A Ximenes; Heloísa L Ramos; Demócrito B Miranda Filho; Carolina D P Freitas; Rosangela M S Silva; Isabella Coimbra; Joanna d'Arc L Batista; Ulisses R Montarroyos; Maria de Fátima P Militão Albuquerque Journal: BMC Public Health Date: 2011-09-05 Impact factor: 3.295
Authors: L Cieply; R Simmons; S Ijaz; E Kara; A Rodger; W Rosenberg; A McGuinness; J L Mbisa; J Ledesma; N Ohemeng-Kumi; S Dicks; H Potts; S Lattimore; S Mandal Journal: Epidemiol Infect Date: 2019-01 Impact factor: 2.451
Authors: Isabel Foster; Amanda Sullivan; Goodman Makanda; Ingrid Schoeman; Phumeza Tisile; Helene-Mari van der Westhuizen; Grant Theron; Ruvandhi R Nathavitharana Journal: BMC Public Health Date: 2022-01-28 Impact factor: 3.295
Authors: Rishi K Gupta; Swaib A Lule; Maria Krutikov; Lara Gosce; Nathan Green; Jo Southern; Ambreen Imran; Robert W Aldridge; Heinke Kunst; Marc Lipman; William Lynn; Helen Burgess; Asif Rahman; Dee Menezes; Ananna Rahman; Simon Tiberi; Peter J White; Ibrahim Abubakar Journal: Eur Respir J Date: 2021-06-24 Impact factor: 16.671